December 10, 2021
Division of Corporation Finance
Office of Technology
Securities and Exchange Commission
100 F Street, NE
Washington, D.C 20549
| Re: | ClearLight Biotechnologies, Inc. | |
| Offering Statement on Form 1-A | ||
| Filed November 19, 2021 | ||
| Amendment No. 1 filed December 2, 2021 | ||
| File No. 024-11720 (the "Offering Statement") |
Ladies and Gentlemen:
In response to your letter of November 30, 2021, please be advised that on December 5, 2021, ClearLight Biotechnologies, Inc. ("ClearLight"), registered the offering by Coordination in the state of
Colorado. ClearLight also filed a Limited Offering Exemption Notice in the state of California on December 6, 2021.
No participant in the Offering is required to clear its compensation arrangement with FINRA.
Please qualify the Offering Statement on December 13, 2021 at 9 am Eastern time.
| Very truly yours, | |||
| /s/ Albert Hansen | |||
| Albert Hansen | |||
| CEO of ClearLight |
cc: Karen Muller, Esq., counsel to ClearLight
Olivia Bobes, SEC Law Clerk